➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sodium propionate

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Sodium propionate?

Sodium propionate is an investigational drug.

There have been 4 clinical trials for Sodium propionate. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.

The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Bronchiolitis Obliterans. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), Lee, Stephanie, and National Cancer Institute (NCI).

Recent Clinical Trials for Sodium propionate
Targeted Therapy of Bronchiolitis Obliterans SyndromeNational Cancer Institute (NCI)Phase 2
Targeted Therapy of Bronchiolitis Obliterans SyndromeLee, StephaniePhase 2
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)Merck Sharp & Dohme Corp.Phase 3

See all Sodium propionate clinical trials

Clinical Trial Summary for Sodium propionate

Top disease conditions for Sodium propionate
Top clinical trial sponsors for Sodium propionate

See all Sodium propionate clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.